Voyageur Pharmaceuticals Ltd (VM.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 11/30
(Values in thousands)
| 11-2025 | 11-2024 | 11-2023 | 11-2022 | 11-2021 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 1 | 2 | 2 | 9 | 2 |
| Accounts receivable | -82 | -16 | -12 | 18 | -29 |
| Accounts payable and accrued liabilities | N/A | N/A | N/A | -192 | -82 |
| Other Working Capital | -171 | 927 | 110 | -244 | -343 |
| Other Operating Activity | -2,641 | -1,215 | -1,092 | -1,309 | -1,203 |
| Operating Cash Flow | $-2,893 | $-302 | $-991 | $-1,719 | $-1,654 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | 0 | 9 | N/A |
| Other Investing Activity | -270 | -166 | -175 | -283 | -432 |
| Investing Cash Flow | $-270 | $-166 | $-175 | $-274 | $-432 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | 0 | -17 | -19 |
| Common Stock Issued | 914 | 656 | 1,200 | 1,157 | 2,305 |
| Other Financing Activity | 2,350 | -24 | -63 | 71 | 610 |
| Financing Cash Flow | $3,264 | $632 | $1,136 | $1,211 | $2,896 |
| Beginning Cash Position | 166 | 2 | 32 | 813 | 3 |
| End Cash Position | 267 | 166 | 2 | 32 | 813 |
| Net Cash Flow | $101 | $163 | $-29 | $-781 | $810 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,893 | -302 | -991 | -1,719 | -1,654 |
| Free Cash Flow | -2,893 | -302 | -991 | -1,719 | -1,654 |